Stock Scorecard

Stock Summary for Elevai Labs Inc (ELAB) - $0.02 as of 11/20/2024 11:51:08 PM EST

Total Score

15 out of 30

Currently on the following lists
Small Cap Stock List
Tim's Recommendation
Possible Buy

Growth List Algorithm Criteria for ELAB

Positive earnings growth
P/E ratio less than Industry P/E Ratio
P/E ratio less than Sector P/E Ratio
P/E ratio that is half the growth rate (or less)
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Positive net income past year and 12 trailing months
Free cash flow ratio greater than 0 and less than 10

Small Cap List Algorithm Criteria for ELAB

Revenue growing by at least 20% average per year over the last 5 years
Market Capitalization under 2 billion
Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months
Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months
Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year

Dividend List Algorithm Criteria for ELAB

Declared an ex-dividend date
Forward annual dividend rate greater than 2
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Current ratio most recent quarter greater than 2
Cash Flow per Share greater than Trailing Dividend Rate

Bonus Criteria for ELAB

P/E ratio less than five-year Average P/E ratio
Last Price to 52 Week Low Ratio Less Than 1
Total Cash Per Share > Last Day Price
P/S Ratio < 1
P/B Ratio < 1

Safety Rating Criteria for ELAB (23 out of 90)

Stock Price Rating (Max of 10) 1
Historical Stock Price Rating (Max of 10) 1
Stock Price Trend (Max of 10) 0
Book Value (Max of 10) 1
Book Value to Price (Max of 10) 10
Analyst Buy Ratings (Max of 5) 0
Analyst Strong Buy Ratings (Max of 5) 0
Dividend Yield Percentage (Max of 10) 0
Operating Margin (Max of 10) 0
Trading Volume (Max of 10) 10
Price to Earnings (Max of 10) 0

Latest News for for ELAB

CORRECTION - Elevai Labs Inc. 11/14/2024 7:35:00 PM
US Stocks Edge Lower; Cisco Earnings Top Views - Cisco Systems ( NASDAQ:CSCO ) 11/14/2024 2:55:00 PM
Elevai Labs Inc. Reports Financial Results for the Second Fiscal Quarter of 2024 and Provides Business Update 11/14/2024 2:08:00 PM
Why DLocal Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving Premarket - DLocal ( NASDAQ:DLO ) 11/14/2024 10:12:00 AM
Why Palantir Shares Are Trading Higher By Around 13%; Here Are 20 Stocks Moving Premarket - Palantir Technologies ( NYSE:PLTR ) 11/5/2024 10:43:00 AM
Elevai Labs Inc. Announces Update and Extension of Pending Offer to Exchange 11/4/2024 10:45:00 PM
Dow Jumps 400 Points; US Adds 12,000 Jobs In October - Proto Labs ( NYSE:PRLB ) 11/1/2024 2:43:00 PM
Why Charter Communications Shares Are Trading Higher By Around 11%; Here Are 20 Stocks Moving Premarket - Charter Communications ( NASDAQ:CHTR ) 11/1/2024 1:15:00 PM
Why Carvana Shares Are Trading Higher By Around 20%; Here Are 20 Stocks Moving Premarket - Carvana ( NYSE:CVNA ) 10/31/2024 10:52:00 AM
Elevai Biosciences, a Subsidiary of Elevai Labs Inc., Engages Leading Contract Research Organization ( CRO ) to Support Regulatory Planning Efforts and Pre-IND Meeting with the Food and Drug Administration For EL-22 For The Treatment of Obesity 10/22/2024 1:54:00 PM

Financial Details for ELAB

Company Overview
Ticker ELAB
Company Name Elevai Labs Inc
Country USA
Description N/A
Sector Name LIFE SCIENCES
Industry Name PHARMACEUTICAL PREPARATIONS
Most Recent Quarter 6/30/2024
Next Earnings Date N/A

Stock Price History
Last Day Price 0.02
Price 4 Years Ago 0.00
Last Day Price Updated 11/20/2024 11:51:08 PM EST
Last Day Volume 199,363,090
Average Daily Volume 214,205,414
52-Week High 4.24
52-Week Low 0.02
Last Price to 52 Week Low 0.00%

Valuation Measures
Trailing PE N/A
Industry PE 22.60
Sector PE 40.32
5-Year Average PE -0.37
Free Cash Flow Ratio 0.06
Industry Free Cash Flow Ratio 12.03
Sector Free Cash Flow Ratio 27.97
Current Ratio Most Recent Quarter 3.86
Total Cash Per Share 0.31
Book Value Per Share Most Recent Quarter 0.14
Price to Book Ratio 2.35
Industry Price to Book Ratio 5.31
Sector Price to Book Ratio 20.88
Price to Sales Ratio Twelve Trailing Months 2.61
Industry Price to Sales Ratio Twelve Trailing Months 11.82
Sector Price to Sales Ratio Twelve Trailing Months 7.11
Analyst Buy Ratings N/A
Analyst Strong Buy Ratings N/A

Share Statistics
Total Shares Outstanding 20,804,600
Market Capitalization 416,092
Institutional Ownership N/A

Dividends
Ex-Dividend Date N/A
Last Dividend Amount 0.00
Current Dividend Amount 0.00
Total Years Dividend Increasing N/A
Trailing Annual Dividend Rate 0.00
Trailing Annual Dividend Yield 0.00%
Forward Annual Dividend Rate 0.00
Forward Annual Dividend Yield 0.00%
5-Year Dividend Payments Count 0
3-Year Average Dividend Yield 0.00%
5-Year Average Dividend Yield 0.00%
1-Year Dividend Growth Rate Percentage 0.00%
3-Year Dividend Growth Rate Percentage 0.00%
5-Year Dividend Growth Rate Percentage 0.00%
All-Time Dividend Growth Rate Percentage 0.00%
Dividend Payout Ratio N/A

Income Statement
Quarterly Earnings Growth YOY 0.00%
Annual Earnings Growth -448.15%
Reported EPS 12 Trailing Months -0.42
Reported EPS Past Year -0.23
Reported EPS Prior Year -0.07
Net Income Twelve Trailing Months 3,134,988,485
Net Income Past Year -4,301,517
Net Income Prior Year -784,739
Quarterly Revenue Growth YOY 91.30%
5-Year Revenue Growth 92,557.44%
Operating Margin Twelve Trailing Months -2.32

Balance Sheet
Total Cash Most Recent Quarter 6,425,670
Total Cash Past Year 3,326,851
Total Cash Prior Year 1,154,901
Net Cash Position Most Recent Quarter 5,355,959
Net Cash Position Past Year 3,326,851
Long Term Debt Past Year 0
Long Term Debt Prior Year 0
Total Debt Most Recent Quarter 1,069,711
Equity to Debt Ratio Past Year 1.00
Equity to Debt Ratio Most Recent Quarter 0.89
Total Stockholder Equity Past Year 3,827,076
Total Stockholder Equity Prior Year 1,131,310
Total Stockholder Equity Most Recent Quarter 8,555,222

Free Cash Flow
Free Cash Flow Twelve Trailing Months 2,171,626,083
Free Cash Flow Per Share Twelve Trailing Months 104.38
Free Cash Flow Past Year -4,568,002
Free Cash Flow Prior Year 0

Options
Put/Call Ratio 0.00
Has Options False
Liquidity Rating None

Technical Analysis
Yahoo Finance Chart Yahoo Finance Chart
MACD -0.03
MACD Signal -0.03
20-Day Bollinger Lower Band -0.10
20-Day Bollinger Middle Band 0.23
20-Day Bollinger Upper Band 0.55
Beta 0.00
RSI 36.18
50-Day SMA 0.00
150-Day SMA 0.00
200-Day SMA 0.00

System
Modified 11/20/2024 11:51:09 PM EST